MISSISSAUGA, ON, Aug. 21, 2020 /CNW/ - Covalon Technologies Ltd.
(the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an
advanced medical technologies company, will be releasing its Fiscal
2020 Third Quarter financial results on Monday August 24th, 2020, before
markets open.
A conference call to discuss Covalon's Fiscal 2020 Q3 Financial
Results will be held on Monday August
24th, 2020, at 9:00am
EST. To participate in the call, please dial:
Local: 416.764.8659
North American Toll-Free: 1.888.664.6392
Confirmation Number: 80896464
A recording of the call will be available until September 7th, 2020, by calling
416.764.8677 or 1.888.390.0541 and entering the encore replay entry
code 896464#. A recording of the call will also be available at
https://ir.covalon.com/events.
Copies of Covalon's financial statements and MD&A can be
obtained on SEDAR at www.sedar.com, as well as at
https://ir.covalon.com/sedar-filings.
About Covalon
Covalon Technologies Ltd. researches, develops, and
commercializes new healthcare technologies that help save lives
around the world. Covalon's patented technologies, products, and
services address the advanced healthcare needs of medical device
companies, healthcare providers, and individual consumers.
Covalon's technologies are used to prevent, detect, and manage
medical conditions in specialty areas such as infection control,
vascular access, surgical procedures, advanced wound care, and
medical device coatings. To learn more about Covalon, visit our
website at www.covalon.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
This news release contains forward-looking statements which
reflect the Company's current expectations regarding future events.
The forward-looking statements are often, but not always,
identified by the use of words such as "seek", "anticipate", "plan,
"estimate", "expect", "intend" and statements that an event or
result "may", "will", "should", "could" or "might" occur or be
achieved and other similar expressions. These forward-looking
statements involve risk and uncertainties, including completion of
integration of the AquaGuard acquisition, the difficulty in
predicting product approvals, acceptance of and demands for new
products, the impact of the products and pricing strategies of
competitors, delays in developing and launching new products, the
regulatory environment, fluctuations in operating results and other
risks, any of which could cause results, performance, or
achievements to differ materially from the results discussed or
implied in the forward-looking statements. Many risks are inherent
in the industry; others are more specific to the Company. Investors
should consult the Company's ongoing quarterly filings for
additional information on risks and uncertainties relating to these
forward-looking statements. Investors should not place undue
reliance on any forward-looking statements. The Company assumes no
obligation to update or alter any forward-looking statements
whether as a result of new information, further events or
otherwise.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/covalon-announces-conference-call-to-discuss-third-quarter-financial-results-301116638.html
SOURCE Covalon Technologies Ltd.